High intrathecal levels of anti-myelin basic protein (MBP) IgM were previously found to be significantly associated with early favorable course in a cohort of patients with multiple sclerosis (MS). A mAb to MBP 105-120 recognizing the 222-228 epitope of the extracellular domain of high affinity immunoglobulin gamma Fc-receptor I (CD64) was isolated from EBV(+) B cell clones of long-term stable RRMS patients. This mAb exerted immunosuppressive activity on MS-derived T cell lines through induction and release of high amounts of interleukin-10 and decreased levels of interleukin-12 from activated monocytes providing the biological basis for a potential new treatment for MS and other immune-mediated neurological disorders.
Scheda prodotto non validato
Scheda prodotto in fase di analisi da parte dello staff di validazione
|Titolo:||Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.|
|Citazione:||Annunziata, P., Cioni, C., Cantalupo, L., DI GENOVA, G., GORI SAVELLINI, G., & Cusi, M.G. (2013). Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis. JOURNAL OF NEUROIMMUNOLOGY, 256(1-2), 62-70.|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto: